Ascelia Pharma AB
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- Public
- Established
- 1999-01-01
- Employees
- 13
- Market Cap
- -
- Website
- http://www.cmc-contrast.se
Clinical Trials
8
Active:5
Completed:1
Trial Phases
2 Phases
Phase 1:7
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
Phase 1
7 (87.5%)Phase 3
1 (12.5%)Safety and Diagnostic Efficacy of Mangoral in Participants With Focal Liver Lesions and Reduced Kidney Function
Phase 3
Completed
- Conditions
- Severe Renal ImpairmentKnown or Suspected Focal Liver Lesions
- Interventions
- First Posted Date
- 2019-10-08
- Last Posted Date
- 2025-02-06
- Lead Sponsor
- Ascelia Pharma AB
- Target Recruit Count
- 87
- Registration Number
- NCT04119843
- Locations
- 🇺🇸
Mayo Clinic - Arizona, Scottsdale, Arizona, United States
🇺🇸University of California at Los Angeles Ronald Reagan Medical Center, Los Angeles, California, United States
🇺🇸Stanford University School of Medicine, Stanford, California, United States
News
No news found